Literature DB >> 8432268

Neurotoxic syndromes and occupational exposure to solvents.

J Juntunen1.   

Abstract

Neurotoxic syndromes due to occupational solvent exposure present a worldwide health problem, the magnitude of which varies from country to country. Apart from the relatively clear-cut exposure-effect relationships in acute solvent intoxications, those caused by long-term, low-level occupational exposure to solvents are more difficult to detect. Controversial opinions and even debate are frequently encountered in literature on this matter. This is partly due to differences in neurobehavioral methods used, partly to difficulties in obtaining accurate information about exposure. These effects can be studied in humans using biochemical, clinical, and epidemiological methods. It is thus quite conceivable that direct comparison of the results obtained by different methods is not always possible. Moreover, exposure to a variable mixture of solvents is frequent in an occupational setting which is problematic from the toxicological point of view. The clinical pictures of "chronic" occupational solvent intoxications are, with few exceptions, quite nonspecific in nature and share several common features regardless of the underlying chemical exposure. The development of manifest disease is insidious and high interindividual variation of symptoms and signs exists. Some solvents cause primarily peripheral neuropathy. Deterioration in many psychological and neurophysiological functions can be seen. The most common subjective symptoms of solvent intoxication are headache, tiredness, memory disturbances, and dizziness. Clinical findings comprise signs of the central nervous system depression (psychoorganic syndrome, tiredness), dizziness, disturbances in coordination, and general neurasthenic signs. From the clinical point of view, it is important to define the criteria for a diagnosis. In different countries the diagnostic criteria for solvent intoxication may vary considerably, which provides additional difficulties in interpreting the results of studies in this field.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432268     DOI: 10.1006/enrs.1993.1019

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  8 in total

1.  Survey of solvent related chronic encephalopathy as an occupational disease in European countries.

Authors:  G Triebig; J Hallermann
Journal:  Occup Environ Med       Date:  2001-09       Impact factor: 4.402

2.  Routine diagnostic procedures for chronic encephalopathy induced by solvents: survey of experts.

Authors:  J A van der Hoek; M M Verberk; G van der Laan; G Hageman
Journal:  Occup Environ Med       Date:  2001-06       Impact factor: 4.402

3.  Persistent cognitive functioning deficits in operating rooms: two cases.

Authors:  Elsa Dreyfus; Eve Tramoni; Marie-Pascale Lehucher-Michel
Journal:  Int Arch Occup Environ Health       Date:  2008-02-08       Impact factor: 3.015

4.  Symptom screening in detection of occupational solvent-related encephalopathy.

Authors:  Ari Kaukiainen; Ritva Akila; Rami Martikainen; Markku Sainio
Journal:  Int Arch Occup Environ Health       Date:  2008-07-05       Impact factor: 3.015

5.  Neurological signs in relation to cancer in patients with asbestosis.

Authors:  J Juntunen; P Oksa; E Pukkala; P Laippala
Journal:  Occup Environ Med       Date:  1997-10       Impact factor: 4.402

6.  Occupational chronic solvent encephalopathy in Finland 1995-2007: incidence and exposure.

Authors:  Petra Keski-Säntti; Ari Kaukiainen; Hanna-Kaisa Hyvärinen; Markku Sainio
Journal:  Int Arch Occup Environ Health       Date:  2009-11-26       Impact factor: 3.015

7.  Magnetic resonance imaging in occupational chronic solvent encephalopathy.

Authors:  Petra Keski-Säntti; Riitta Mäntylä; Antti Lamminen; Hanna-Kaisa Hyvärinen; Markku Sainio
Journal:  Int Arch Occup Environ Health       Date:  2008-10-21       Impact factor: 3.015

8.  Time may not fully attenuate solvent-associated cognitive deficits in highly exposed workers.

Authors:  Erika L Sabbath; Laure-Anne Gutierrez; Cassandra A Okechukwu; Archana Singh-Manoux; Hélène Amieva; Marcel Goldberg; Marie Zins; Claudine Berr
Journal:  Neurology       Date:  2014-05-13       Impact factor: 9.910

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.